Verantos offers RWE solutions that are as advanced as your therapy
Verantos provides clearer insights based on our real-world evidence platform to generate high-validity results. Our approach, which engages health systems directly and utilizes the entire patient record, including unstructured EHR clinical narrative, provides a robust view of the patient journey, including disease severity, treatment, symptom control, and clinical outcome parameters.

The Verantos
solution advantage
Our solutions include the following:

Our solutions advance the state of the art in the following functions.
Market access
- More credible evidence to help payers and health technology assessment (HTA) bodies understand the value of today’s therapies
- High-reliability RWD your teams can use to generate high-validity real-world evidence, which is necessary for credibility in conversations with payers
- Rapid time-to-value, shortening the delay in moving from UM-controlled access to preferred brand tier
Pharmacovigilance
- Pragmatic registries from high-accuracy RWD reduce false positives in potential safety signals
- Better safety contextualization of patients experiencing adverse reactions
- Earlier detection of real-world safety signals from more representative populations to reduce risk of onerous post-marketing studies
Clinical development
- Complete view of the patient journey without the overhead of consented registries
- Patients from community health systems and academic medical centers and provide more representative outcomes
- Larger sample sizes with more granular phenotyping